Document is current
Any future updates will be listed below
-
Authors
Lewis, Michael https://orcid.org/0000-0002-7552-703X
Terré, Berta
Knobel, Philip A.
Cheng, Tao
Lu, Hao
Attolini, Camille Stephan-Otto
Smak, Jordann
Coyaud, Etienne
Garcia-Cao, Isabel https://orcid.org/0000-0002-4582-0403
Sharma, Shalu
Vineethakumari, Chithran https://orcid.org/0000-0002-3802-1283
Querol, Jessica
Gil-Gómez, Gabriel https://orcid.org/0000-0002-9790-7308
Piergiovanni, Gabriele https://orcid.org/0000-0003-3954-207X
Costanzo, Vincenzo
Peiró, Sandra
Raught, Brian
Zhao, Haotian https://orcid.org/0000-0003-2315-8452
Salvatella, Xavier https://orcid.org/0000-0002-8371-4185
Roy, Sudipto
Mahjoub, Moe R.
Stracker, Travis H. https://orcid.org/0000-0002-8650-2081
- License Information
-
More Information
Article History
Received: 7 October 2022
Revised: 28 February 2023
Accepted: 1 March 2023
First Online: 17 March 2023
Competing interests
: XS is a founder and scientific advisor of Nuage Therapeutics. All other authors declare no conflicts of interest.
